Working… Menu

Inflammatory Cardiomyopathy Baseline Cohort (SFB/TR19) (SFB/TR19)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02970227
Recruitment Status : Completed
First Posted : November 21, 2016
Last Update Posted : November 22, 2016
Information provided by (Responsible Party):
University Medicine Greifswald

Brief Summary:
cohort of cardiomyopathy patients (suspected or validated inflammatory cardiomyopathy) recruited at baseline by the SFB-TR19 project. Standardized protocols used for the assessment of medical history and examinations, laboratory biomarkers, and the collection of various biosamples for biobanking purposes.

Condition or disease Intervention/treatment
Cardiomyopathies Heart Failure Other: Observation

Layout table for study information
Study Type : Observational [Patient Registry]
Actual Enrollment : 920 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 12 Years
Official Title: Inflammatory Cardiomyopathy Cohort of the SFB/TR19 [Kohorte "Entzündliche Kardiomyopathien" Des Sonderforschungsbereichs/Transregio 19 (SFB/TR19)]
Study Start Date : January 2004
Actual Primary Completion Date : June 2015
Actual Study Completion Date : June 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Cardiomyopathy

Intervention Details:
  • Other: Observation
    None, observation only

Primary Outcome Measures :
  1. Cardiovascular events [ Time Frame: 1-year follow-ups ]
    Hospitalization (HF based. all-cause), interventions (ICD, pacemaker), myocardial infarction

Secondary Outcome Measures :
  1. LVEF [ Time Frame: 1-year follow-ups ]
    Left ventricular ejection fraction at time of follow-up

  2. VO2peak [ Time Frame: 1-year follow-ups ]
    Exercise capacity by CPET

  3. QOL [ Time Frame: 1-year follow-ups ]
    Quality of life by questionnaire (Minnesota Living with HF questionnaire)

  4. Mortality [ Time Frame: 1-year follow-ups ]
    Mortality (HF-related, CVD, all-cause)

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with suspected or validated inflammatory cardiomyopathy at baseline

Inclusion Criteria:

  • suspected inflammatory cardiomyopathy at baseline

Exclusion Criteria:

  • none

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02970227

Layout table for location information
Department of Internal Medicine B, University Medicine Greifswald
Greifswald, MV, Germany, 17475
Sponsors and Collaborators
University Medicine Greifswald

Additional Information:

Layout table for additonal information
Responsible Party: University Medicine Greifswald Identifier: NCT02970227     History of Changes
Other Study ID Numbers: SFB/TR19-001
First Posted: November 21, 2016    Key Record Dates
Last Update Posted: November 22, 2016
Last Verified: November 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by University Medicine Greifswald:
heart failure
Additional relevant MeSH terms:
Layout table for MeSH terms
Heart Failure
Heart Diseases
Cardiovascular Diseases